This company listing is no longer active
Resumen de acción NXTMS
Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Competidores de Nexstim Plc
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €40.40 |
| 52 Week High | €56.90 |
| 52 Week Low | €36.00 |
| Beta | 1.67 |
| 1 Month Change | 1.64% |
| 3 Month Change | -10.32% |
| 1 Year Change | -26.14% |
| 3 Year Change | -46.13% |
| 5 Year Change | -99.44% |
| Change since IPO | -99.98% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| NXTMS | SE Medical Equipment | Mercado SE | |
|---|---|---|---|
| 7D | 1.0% | 2.3% | 0.1% |
| 1Y | -26.1% | -5.4% | 11.2% |
Rentabilidad vs. Industria: NXTMS exceeded the Swedish Medical Equipment industry which returned -31.6% over the past year.
Rentabilidad vs. Mercado: NXTMS underperformed the Swedish Market which returned -9.3% over the past year.
Volatilidad de los precios
| NXTMS volatility | |
|---|---|
| NXTMS Average Weekly Movement | 6.1% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in SE Market | 13.5% |
| 10% least volatile stocks in SE Market | 3.6% |
Precio estable de las acciones: NXTMS has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: NXTMS's weekly volatility (6%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2000 | 39 | Mikko Karvinen | www.nexstim.com |
Resumen de fundamentos de Nexstim Plc
| Estadísticas fundamentales de NXTMS | |
|---|---|
| Capitalización bursátil | kr288.81m |
| Beneficios(TTM) | kr14.79m |
| Ingresos (TTM) | kr121.81m |
19.5x
Ratio precio-beneficio (PE)2.4x
Ratio precio-ventas (PS)¿Está NXTMS sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de NXTMS | |
|---|---|
| Ingresos | €10.76m |
| Coste de los ingresos | €1.24m |
| Beneficio bruto | €9.52m |
| Otros gastos | €8.21m |
| Beneficios | €1.31m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
Aug 18, 2023
| Beneficios por acción (BPA) | 0.19 |
| Margen bruto | 88.47% |
| Margen de beneficio neto | 12.14% |
| Ratio deuda/patrimonio | 85.8% |
¿Cómo se ha desempeñado NXTMS a largo plazo?
Ver rendimiento histórico y comparativa